Last reviewed 2026-04-20 · How we verify

RADIOGARDASE (PRUSSIAN BLUE) (FERRIC HEXACYANOFERRATE(II))

HEYL CHEMISCH · FDA-approved approved Quality 13/100

RADIOGARDASE (PRUSSIAN BLUE) (generic name: FERRIC HEXACYANOFERRATE(II)) is a drug developed by HEYL CHEMISCH. It is currently FDA-approved for Radioactive Cesium Decontamination, Thallium poisoning.

At a glance

Generic name	FERRIC HEXACYANOFERRATE(II)
Sponsor	HEYL CHEMISCH
Therapeutic area	Other
Phase	FDA-approved

Approved indications

Radioactive Cesium Decontamination
Thallium poisoning

Common side effects

No common side effects on file.

Key clinical trials

Sputum-guided Treatment With Comprehensive Care Management for Respiratory Improvement to Provide Value and Escalate Care - A Randomized-controlled Trial (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

RADIOGARDASE (PRUSSIAN BLUE) CI brief — competitive landscape report
RADIOGARDASE (PRUSSIAN BLUE) updates RSS · CI watch RSS
HEYL CHEMISCH portfolio CI

Frequently asked questions about RADIOGARDASE (PRUSSIAN BLUE)

What is RADIOGARDASE (PRUSSIAN BLUE)?

RADIOGARDASE (PRUSSIAN BLUE) (FERRIC HEXACYANOFERRATE(II)) is a pharmaceutical drug developed by HEYL CHEMISCH, indicated for Radioactive Cesium Decontamination, Thallium poisoning.

What is RADIOGARDASE (PRUSSIAN BLUE) used for?

RADIOGARDASE (PRUSSIAN BLUE) is indicated for Radioactive Cesium Decontamination, Thallium poisoning.

Who makes RADIOGARDASE (PRUSSIAN BLUE)?

RADIOGARDASE (PRUSSIAN BLUE) is developed and marketed by HEYL CHEMISCH (see full HEYL CHEMISCH pipeline at /company/heyl-chemisch).

What is the generic name of RADIOGARDASE (PRUSSIAN BLUE)?

FERRIC HEXACYANOFERRATE(II) is the generic (nonproprietary) name of RADIOGARDASE (PRUSSIAN BLUE).

What development phase is RADIOGARDASE (PRUSSIAN BLUE) in?

RADIOGARDASE (PRUSSIAN BLUE) is FDA-approved (marketed).

Manufacturer: HEYL CHEMISCH — full pipeline
Therapeutic area: All drugs in Other
Indication: Drugs for Radioactive Cesium Decontamination
Indication: Drugs for Thallium poisoning

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing